Singular Bio, Inc. (Acquired by Invitae in June 2019) Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Singular Bio, Inc. is a biotechnology research company focused on applying human genome analysis to healthcare screening at scale. Its testing platform is designed to deliver the performance of genetic analysis alongside the low cost and rapid turnaround characteristic of screening assays, enabling broad population health testing. The tests are intended to support early disease detection and to reduce unnecessary medical procedures. The company is based in San Francisco, California, in the Mission Bay area, and operates as a small to mid-sized biotechnology research firm. In June 2019, Singular Bio was acquired by Invitae, integrating its technology and team into a larger genomics company.